Genetic Counseling for Breast Cancer Survivors (GC for BC) (NCT02451735) | Clinical Trial Compass
CompletedNot Applicable
Genetic Counseling for Breast Cancer Survivors (GC for BC)
United States157 participantsStarted 2012-07-27
Plain-language summary
The purpose of this study is to review and evaluate the effectiveness of new educational materials (informational booklet \& DVD) that promote participation in genetic counseling among breast cancer survivors.
There are two phases to this study:
Part 1 - reviewing the newly developed educational materials, and Part 2 - evaluating the effectiveness of the newly developed educational materials
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Part 1: Female breast cancer patients at Moffitt Cancer Center (MCC) are eligible to participate if they:
* are \> 18 years of age;
* have no documented or observable psychiatric or neurological disorders that would interfere with study participation (e.g., dementia, psychosis);
* are capable of speaking and reading standard English;
* have not attended or scheduled an upcoming appointment for genetic counseling at the time of recruitment;
* are within 18 months of their breast cancer (BC) diagnosis;
* have a previous diagnosis of breast cancer or;
* received a referral letter for GC from their MCC physician;
* breast cancer at age 50 or below;
* bilateral breast cancer;
* multiple cancers except basal cell carcinoma;
* triple negative breast cancer;
* ovarian cancer or fallopian tube cancer at any age;
* of Ashkenazi Jewish descent;
* have 2 or more blood relatives diagnosed with breast cancer;
* have any blood relatives diagnosed with bilateral breast cancer;
* a first degree relative diagnosed with breast cancer below age 50;
* have blood relatives diagnosed with ovarian cancer;
* have 2 or more family members on the same side of the family with breast, ovarian, pancreatic, or prostate cancer;
* have a known cancer gene mutation (such as BRCA 1/2;
* have any male relatives diagnosed with breast cancer ; and
* have a mailing address and working telephone number; and
* provide written informed consent.
Part 2: Female BC patients at MCC are eligible to …
What they're measuring
1
Part 1: Rate of Initial Survey Responses
Timeframe: Up to 8 months
2
Part 2: Rate of Participation
Timeframe: Up to 8 months
Trial details
NCT IDNCT02451735
SponsorH. Lee Moffitt Cancer Center and Research Institute